Table 2.
Doses of buprenorphine and doxorubicin for experiments
| Buprenorphine | Doxorubicin | |
|---|---|---|
| Transitional cell carcinoma (K9TCC) | 0.5 μg/ml | 0.500 μg/ml |
| Osteosarcoma (Abrams) | 0.5 μg/ml | 0.100 μg/ml |
| Hemangiosarcoma (DAL‐4) | 0.5 μg/ml | 0.015 μg/ml |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.